Tevogen Bio Ownership 2024 | Who Owns Tevogen Bio Now?
Institutional Ownership
8.02%
Insider Ownership
88.94%
Retail Ownership
3.04%
Institutional Holders
7.00
Tevogen Bio Institutional Shareholders
Institutional Shareholders by % of Total Shares
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
GLAZER CAPITAL, LLC | - | - | - | -149,534 | -100.00% | - | Mar 31, 2024 |
WESTCHESTER CAPITAL MANAGEMENT, LLC | - | - | - | -99,949 | -100.00% | - | Mar 31, 2024 |
CENTIVA CAPITAL, LP | - | - | - | -100,000 | -100.00% | - | Mar 31, 2024 |
CLEAR STREET LLC | - | - | - | -600 | -100.00% | - | Mar 31, 2024 |
KIM, LLC | - | - | - | -50,000 | -100.00% | - | Mar 31, 2024 |
METEORA CAPITAL, LLC | - | - | - | -505,670 | -100.00% | - | Mar 31, 2024 |
QUARRY LP | - | - | - | -55,000 | -100.00% | - | Mar 31, 2024 |
Tevogen Bio's largest institutional shareholder is GLAZER CAPITAL, LLC, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.
Institutional Shareholders by % of Total Assets
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
GLAZER CAPITAL, LLC | - | - | - | -149,534 | -100.00% | - | Mar 31, 2024 |
WESTCHESTER CAPITAL MANAGEMENT, LLC | - | - | - | -99,949 | -100.00% | - | Mar 31, 2024 |
CENTIVA CAPITAL, LP | - | - | - | -100,000 | -100.00% | - | Mar 31, 2024 |
CLEAR STREET LLC | - | - | - | -600 | -100.00% | - | Mar 31, 2024 |
KIM, LLC | - | - | - | -50,000 | -100.00% | - | Mar 31, 2024 |
METEORA CAPITAL, LLC | - | - | - | -505,670 | -100.00% | - | Mar 31, 2024 |
QUARRY LP | - | - | - | -55,000 | -100.00% | - | Mar 31, 2024 |
The largest Tevogen Bio shareholder by % of total assets is GLAZER CAPITAL, LLC. The company owns 0.00 shares of Tevogen Bio (LGST), representing 0.00% of its total assets.
Institutional Buyers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
CLEAR STREET LLC | - | - | - | -600 | -100.00% | - | Mar 31, 2024 |
KIM, LLC | - | - | - | -50,000 | -100.00% | - | Mar 31, 2024 |
QUARRY LP | - | - | - | -55,000 | -100.00% | - | Mar 31, 2024 |
WESTCHESTER CAPITAL MANAGEMENT, LLC | - | - | - | -99,949 | -100.00% | - | Mar 31, 2024 |
CENTIVA CAPITAL, LP | - | - | - | -100,000 | -100.00% | - | Mar 31, 2024 |
GLAZER CAPITAL, LLC | - | - | - | -149,534 | -100.00% | - | Mar 31, 2024 |
METEORA CAPITAL, LLC | - | - | - | -505,670 | -100.00% | - | Mar 31, 2024 |
As of Mar 31 2024, Tevogen Bio's largest institutional buyer is CLEAR STREET LLC. The company purchased -0.60K stocks of LGST, valued at -.
Institutional Sellers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
METEORA CAPITAL, LLC | - | - | - | -505,670 | -100.00% | - | Mar 31, 2024 |
GLAZER CAPITAL, LLC | - | - | - | -149,534 | -100.00% | - | Mar 31, 2024 |
CENTIVA CAPITAL, LP | - | - | - | -100,000 | -100.00% | - | Mar 31, 2024 |
WESTCHESTER CAPITAL MANAGEMENT, LLC | - | - | - | -99,949 | -100.00% | - | Mar 31, 2024 |
QUARRY LP | - | - | - | -55,000 | -100.00% | - | Mar 31, 2024 |
KIM, LLC | - | - | - | -50,000 | -100.00% | - | Mar 31, 2024 |
CLEAR STREET LLC | - | - | - | -600 | -100.00% | - | Mar 31, 2024 |
As of Mar 31 2024, Tevogen Bio's biggest institutional seller is METEORA CAPITAL, LLC. The company sold -0.51M shares of LGST, valued at -.
Institutional New positions
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|
Institutional Sold Out
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
METEORA CAPITAL, LLC | - | - | - | -505,670 | -100.00% | - | Mar 31, 2024 |
GLAZER CAPITAL, LLC | - | - | - | -149,534 | -100.00% | - | Mar 31, 2024 |
CENTIVA CAPITAL, LP | - | - | - | -100,000 | -100.00% | - | Mar 31, 2024 |
WESTCHESTER CAPITAL MANAGEMENT, LLC | - | - | - | -99,949 | -100.00% | - | Mar 31, 2024 |
QUARRY LP | - | - | - | -55,000 | -100.00% | - | Mar 31, 2024 |
KIM, LLC | - | - | - | -50,000 | -100.00% | - | Mar 31, 2024 |
CLEAR STREET LLC | - | - | - | -600 | -100.00% | - | Mar 31, 2024 |
Tevogen Bio's largest sold out institutional shareholder by shares sold is METEORA CAPITAL, LLC, sold -0.51M shares, valued at -, as of undefined.
Tevogen Bio Mutual Fund Holders
Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
---|---|---|---|---|---|
Saba Capital Income & Opportunities Fund | 0.08% | 196,100 | - | - | Jan 31, 2024 |
RIVERPARK FUNDS TRUST | 0.02% | 175,000 | - | - | Dec 31, 2023 |
CALAMOS INVESTMENT TRUST/IL | 0.02% | 2,000,000 | - | - | Jan 31, 2024 |
Investment Managers Series Trust II | 0.02% | 227,903 | - | - | Jan 31, 2024 |
RIVERNORTH OPPORTUNITIES FUND, INC. | 0.01% | 6,402 | - | - | Jan 31, 2024 |
TRUST FOR PROFESSIONAL MANAGERS | 0.00% | 7,865 | - | - | Feb 29, 2024 |
PRINCIPAL FUNDS, INC. | 0.00% | 1,633 | - | - | Feb 29, 2024 |
Tevogen Bio's largest mutual fund holder by % of total assets is "Saba Capital Income & Opportunities Fund", owning 196.10K shares, compromising 0.08% of its total assets.
Tevogen Bio Institutional Ownership Trends
Institutional Holdings Trend
Date | Holdings | Change % |
---|---|---|
31 Dec, 23 | 7 | -46.15% |
30 Sep, 23 | 13 | 160.00% |
30 Jun, 23 | 5 | - |
31 Mar, 23 | 5 | -92.31% |
31 Dec, 22 | 65 | 4.84% |
30 Sep, 22 | 62 | -7.46% |
30 Jun, 22 | 67 | 6.35% |
31 Mar, 22 | 63 | - |
As of 31 Dec 23, 7 institutions are holding Tevogen Bio's shares, representing a decrease of -46.15% compared to the previous quarter.
Shares Outstanding Trend
Date | Shares Outstanding | Change % |
---|---|---|
31 Dec, 23 | 960,753 | -61.16% |
30 Sep, 23 | 2,473,835 | -48.37% |
30 Jun, 23 | 4,791,397 | 0.01% |
31 Mar, 23 | 4,790,721 | -86.14% |
31 Dec, 22 | 34,575,221 | 8.48% |
30 Sep, 22 | 31,871,519 | 2.23% |
30 Jun, 22 | 31,176,131 | 14.85% |
31 Mar, 22 | 27,144,240 | - |
Tevogen Bio (LGST) has 960.75K shares outstanding as of 31 Dec 23, down -61.16% compared to the previous quarter.
Institutional Ownership Trend
Date | Ownership % | Change % |
---|---|---|
31 Dec, 23 | 8.02% | 1.88% |
30 Sep, 23 | 20.64% | 3.78% |
30 Jun, 23 | 23.38% | 4.28% |
31 Mar, 23 | 23.38% | 0.08% |
31 Dec, 22 | 168.72% | 0.70% |
30 Sep, 22 | 155.52% | 0.67% |
30 Jun, 22 | 152.13% | 0.87% |
31 Mar, 22 | 132.46% | - |
As of 31 Dec 23, Tevogen Bio is held by 8.02% institutional shareholders, representing a 1.88% growth compared to 30 Sep 23.
Institutional Increased Positions Trend
Date | Increased Positions | Change % |
---|---|---|
31 Dec, 23 | 4 | -63.64% |
30 Sep, 23 | 11 | 450.00% |
30 Jun, 23 | 2 | -33.33% |
31 Mar, 23 | 3 | -86.36% |
31 Dec, 22 | 22 | 4.76% |
30 Sep, 22 | 21 | 10.53% |
30 Jun, 22 | 19 | -69.35% |
31 Mar, 22 | 62 | - |
4 institutional shareholders have increased their position in LGST stock as of 31 Dec 23 compared to 11 in the previous quarter (a -63.64% decrease).
Institutional Reduced Positions Trend
Date | Reduced Positions | Change % |
---|---|---|
31 Dec, 23 | 2 | - |
30 Sep, 23 | - | - |
30 Jun, 23 | - | - |
31 Mar, 23 | - | -100.00% |
31 Dec, 22 | 13 | 62.50% |
30 Sep, 22 | 8 | - |
30 Jun, 22 | 8 | - |
31 Mar, 22 | - | - |
2 institutional shareholders have reduced their position in LGST stock as of 31 Dec 23 compared to - in the previous quarter (a 0.00% increase).
All Institutional Ownership Trend Data
Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
---|---|---|---|---|---|---|---|---|---|---|
31 Dec, 23 | 7 | -46.15% | 960,753 | -61.16% | 8.02% | 1.88% | 4 | -63.64% | 2 | - |
30 Sep, 23 | 13 | 160.00% | 2,473,835 | -48.37% | 20.64% | 3.78% | 11 | 450.00% | - | - |
30 Jun, 23 | 5 | - | 4,791,397 | 0.01% | 23.38% | 4.28% | 2 | -33.33% | - | - |
31 Mar, 23 | 5 | -92.31% | 4,790,721 | -86.14% | 23.38% | 0.08% | 3 | -86.36% | - | -100.00% |
31 Dec, 22 | 65 | 4.84% | 34,575,221 | 8.48% | 168.72% | 0.70% | 22 | 4.76% | 13 | 62.50% |
30 Sep, 22 | 62 | -7.46% | 31,871,519 | 2.23% | 155.52% | 0.67% | 21 | 10.53% | 8 | - |
30 Jun, 22 | 67 | 6.35% | 31,176,131 | 14.85% | 152.13% | 0.87% | 19 | -69.35% | 8 | - |
31 Mar, 22 | 63 | - | 27,144,240 | - | 132.46% | - | 62 | - | - | - |
Tevogen Bio Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
---|
Insider Sells
All Insider Owners Trades
The last insider sell of Tevogen Bio's stock was made by Corbin Capital Partners, L.P. on Jul 18 2023, selling 1,716,800 shares at $10.68 per share (valued at $18.34M).
Tevogen Bio Insider Ownership Trends
All Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q3 2023 | - | 1 | - |
Q2 2023 | 4 | 5 | 80.00% |
Q1 2023 | 1 | 1 | 100.00% |
0 total buy trades, and 1 total sell trades (buy/sell ratio of 0.00%) were made by Tevogen Bio's insiders, as of Q3 2023.
Open Market Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q3 2023 | - | 1 | - |
Q2 2023 | - | 1 | - |
Q1 2023 | - | - | - |
As of Q3 2023, Insider owners conducted 0 open market buy trades and 1 open market sell trades of Tevogen Bio's stocks.
LGST Ownership FAQ
Who Owns Tevogen Bio?
Tevogen Bio is owned by institutional shareholders (8.02%), insiders (88.94%), and public (3.04%). The largest institutional shareholder of Tevogen Bio is GLAZER CAPITAL, LLC (0% of total shares) and the top mutual fund owner is Saba Capital Income & Opportunities Fund (0.08% of total shares).
Who are the major institutional shareholders of Tevogen Bio?
Tevogen Bio's major institutional shareholders are GLAZER CAPITAL, LLC, WESTCHESTER CAPITAL MANAGEMENT, LLC, CENTIVA CAPITAL, LP, CLEAR STREET LLC, and KIM, LLC. The top five shareholders own together 0% of the company's share outstanding.
How many Tevogen Bio shareholders are there?
As of Dec 2023, there are 7 institutional shareholders of Tevogen Bio.
What percentage of Tevogen Bio is owned by GLAZER CAPITAL, LLC?
GLAZER CAPITAL, LLC owns 0 shares of Tevogen Bio, representing 0% of the company's total shares outstanding, valued at $0 (as of Mar 2024).
What percentage of Tevogen Bio is owned by WESTCHESTER CAPITAL MANAGEMENT, LLC?
As of Mar 2024, WESTCHESTER CAPITAL MANAGEMENT, LLC holds 0 shares of Tevogen Bio (LGST), compromising 0% of the company, valued at $0.
What percentage of Tevogen Bio is owned by CENTIVA CAPITAL, LP?
CENTIVA CAPITAL, LP is the third largest holder of Tevogen Bio. The company owns 0 of the company's shares outstanding (worth $0).